Your browser doesn't support javascript.
loading
Long-term survival benefit of male and multimorbid COVID-19 patients with 5-day remdesivir treatment.
Polivka, Lorinc; Gajdacsi, Jozsef; Fazekas, Levente; Sebok, Szilvia; Barczi, Eniko; Hidvegi, Edit; Sutto, Zoltan; Dinya, Elek; Maurovich-Horvat, Pal; Szabo, Attila J; Merkely, Bela; Müller, Veronika.
Afiliação
  • Polivka L; Department of Pulmonology, Semmelweis University, Budapest, Hungary.
  • Gajdacsi J; Clinical Center, Semmelweis University, Budapest, Hungary.
  • Fazekas L; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Sebok S; University Pharmacy Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary.
  • Barczi E; Department of Pulmonology, Semmelweis University, Budapest, Hungary.
  • Hidvegi E; Department of Pulmonology, Semmelweis University, Budapest, Hungary.
  • Sutto Z; Department of Pulmonology, Semmelweis University, Budapest, Hungary.
  • Dinya E; Institute of Digital Health Sciences, Semmelweis University, Budapest, Hungary.
  • Maurovich-Horvat P; Medical Imaging Centre, Semmelweis University, Budapest, Hungary.
  • Szabo AJ; Clinical Center, Semmelweis University, Budapest, Hungary.
  • Merkely B; 1st Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Müller V; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
J Glob Health ; 12: 05031, 2022 Aug 31.
Article em En | MEDLINE | ID: mdl-36040909

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Coronavirus / Coronavirus / Doença Pulmonar Obstrutiva Crônica / Tratamento Farmacológico da COVID-19 Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Glob Health Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Hungria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Coronavirus / Coronavirus / Doença Pulmonar Obstrutiva Crônica / Tratamento Farmacológico da COVID-19 Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Glob Health Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Hungria